DYAI: C1 Deals Extend Reach to 40% of World
By John Vandermosten, CFA
NASDAQ:DYAI
READ THE FULL DYAI RESEARCH REPORT
Related Posts
Nintendo Clocks 5% Sales Decline In Q1 As Recovery Kicks In; Reiterates FY23 Outlook
Nintendo Co, Ltd (OTC:NTDOY) reported a first-quarter FY23 net sales decline of 4.7% year-on-year to ¥307.4 billion. Dedicated video game platform…
Morgan Stanley Maintains Equal-Weight on Axis Capital Holdings, Lowers Price Target to $55
Morgan Stanley analyst Michael Phillips maintains Axis Capital Holdings (NYSE:AXS) with a Equal-Weight and lowers the price target from $57 to $55.
Aprea Therapeutics Q2 EPS $(0.48) Up From $(0.78) YoY
Aprea Therapeutics (NASDAQ:APRE) reported quarterly losses of $(0.48) per share. This is a 38.46 percent increase over losses of $(0.78) per share from the same period last year.